US Military Mandates Testosterone Screening for Service Members

The U.S. Department of Defense has implemented a new mandatory screening program to test all service members for testosterone deficiency, aiming to optimize performance and long-term health. Defense Secretary Pete Hegseth announced the initiative, stating it focuses on restoring and optimizing natural capabilities rather than artificial enhancement. The program, effective immediately, requires all active duty and reserve component personnel aged 30 and older to undergo screening during their annual Periodic Health Assessment. This measure addresses the natural depletion of testosterone that begins in a person's late 30s, potentially dropping 1% per year. Service members diagnosed with testosterone deficiency may be offered testosterone replacement therapy, with the decision to undergo treatment remaining voluntary. Experts acknowledge that testosterone replacement therapy can offer benefits such as improved sex drive, energy, mood, and bone strength for individuals with a genuine need, as suggested by the 2023 TRAVERSE trial. However, potential risks associated with the therapy include blood thickening, reduced fertility, and breast tissue growth, necessitating careful monitoring, including PSA prostate checks for men over 40. The initiative reflects a commitment to maintaining troops at the "leading edge of lethality" by ensuring they possess the necessary biological foundation.